Statement Of Financial Position [Abstract]

BerGenBio - Filing #2581090

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Non-current assets	43,000 NOK	—	—	—	1,191,000 NOK	—	—	—	—	—	—	—
Current assets [abstract]
Cash and cash equivalents	150,803,000 NOK	—	—	—	436,646,000 NOK	—	—	—	721,641,000 NOK	—	—	—
Current assets	166,663,000 NOK	—	—	—	449,045,000 NOK	—	—	—	—	—	—	—
Assets	166,706,000 NOK	—	—	—	450,236,000 NOK	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	8,866,000 NOK	—	—	—	8,846,000 NOK	—	—	—	—	—	—	—
Share premium	35,780,000 NOK	—	—	—	335,195,000 NOK	—	—	—	—	—	—	—
Equity	88,498,000 NOK	35,780,000 NOK	8,866,000 NOK	43,852,000 NOK	384,426,000 NOK	40,386,000 NOK	335,195,000 NOK	8,846,000 NOK	670,229,000 NOK	8,726,000 NOK	33,272,000 NOK	628,231,000 NOK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	275,000 NOK	—	—	—	942,000 NOK	—	—	—	—	—	—	—
Current liabilities [abstract]
Current provisions [abstract]
Current provisions	0 NOK	—	—	—	969,000 NOK	—	—	—	—	—	—	—
Current liabilities	77,933,000 NOK	—	—	—	64,868,000 NOK	—	—	—	—	—	—	—
Liabilities	78,208,000 NOK	—	—	—	65,810,000 NOK	—	—	—	—	—	—	—
Equity and liabilities	166,706,000 NOK	—	—	—	450,236,000 NOK	—	—	—	—	—	—	—